Atlas FDA

EXABLATE

FDA premarket approval P040003/S010 · decided 2011-12-08

Approval details

PMA number
P040003
Supplement
S010
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
EXABLATE
Generic name
Ablation system, high intensity focused ultrasound (HIFU), MR-guided
Applicant
Insightec, Ltd.
Date received
2011-09-13
Decision date
2011-12-08
Days to decision
86 days
Decision code
APPR
Product code
NRZ
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Dallas, TX
Statement
APPROVAL FOR MODIFICATION OF THE EXABLATE PLATFORM 1) SO THAT THE SAME PLATFORM CAN BE USED WITH MULTIPLE CRADLES; AND 2) TO ENABLE THE CRADLE THAT HAS THE CAPABILITY TO MOVE THE TRANSDUCER IN THE ANTERIOR AND POSTERIOR DIRECTIONS BE USED IN THE LOCKED POSITION FORCOMMERCIAL UTERINE FIBROID TREATMENT.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Exablate Model 2100V1, Exablate Prostate System, Exablate MRgFUS, Exablate 2100V1 Type 3.0 (K231378)Insightec, Ltd.2023-10-30